ESOPJul 6, 2026, 04:07 PM
Madrigal Grants Equity Awards for 604 Shares, 2,952 RSUs
AI Summary
Madrigal Pharmaceuticals, Inc. announced it granted equity inducement awards to seven new non-executive employees on July 1, 2026. These awards, approved by the independent Compensation Committee, included options to purchase 604 shares of common stock and 2,952 time-based restricted stock units. The options have an exercise price of $514.39 per share, and both options and RSUs are subject to multi-year vesting schedules contingent on continued employment.
Key Highlights
- Madrigal granted equity awards to seven new non-executive employees.
- Awards were granted on July 1, 2026, under the 2025 Inducement Plan.
- Employees received options to purchase 604 shares of common stock.
- Employees also received 2,952 time-based restricted stock units (RSUs).
- Option exercise price is $514.39 per share, equal to the closing price on grant date.
- Options vest 25% on the first anniversary, then 6.25% quarterly thereafter.
- RSUs vest in four equal installments on the first through fourth anniversaries.
Price Impact
More from MDGL